6. If I am already being treated, should I switch to a biosimilar?

This patient toolkit has been developed by ecancer in collaboration with the European Cancer Patient Coalition to provide patients with a comprehensive resource on biosimilar medicines. Six modules provide key information and practical advice to support you in making informed decisions for your treatment.

This e-learning resource is supported through an unrestricted education grant from Pfizer.

Ähnliche resourcen

Card image cap
SERIE
>

Biosimilars

Eine Reihe von Videos über Biosimilars, die ihren Einsatz in der Krebsbehandlung erklären.

watch